Leaderboard

En | De
Sie sind hier: Onkologie » Magen-Darm 25. Oktober 2026
Suchen
medline.ch
Magen-Darm
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 12323  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 246457  
   
Routes to Diagnosis and Stage at Diagnosis of Colorectal Cancer in Patients Aged ≥ 50 Years: A Multicentre Retrospective Cohort Study From North Wales, UK.
Cureus
Toquero M, Thiagarajah Naidu S, Williams AD, Waddon J, Emmas R, Das A, Noor A, Balasubaramaniam V, Dixon S.
PMID: 42923923 [PubMed]


Serum metabolomic signatures associated with gastric signet-ring cell carcinoma: A dual-platform mass spectrometry study.
Oncol Lett
Cao H, Guo S, Li J, Bian Y, Shen J, Wang J, Meng F, Sun W, Sun Q, Gu W.
PMID: 42923593 [PubMed]


Efficacy and safety of postoperative chemotherapy with capecitabine and oxaliplatin for advanced gastric cancer.
Am J Transl Res
Wang J, Li Y, Wang H, Cai X.
PMID: 42923190 [PubMed]


LLM-assisted evidence audit of late-stage cancer incidence as a screening trial endpoint.
medRxiv
Li S, Zhang W, Xing X, Shen Z, Wang Y, Chen Z, Neto OBL, Yu Y, Wu C, Lin L.
PMID: 42922838 [PubMed]


The Role of Distress-related Metabolic Dysfunction in Ovarian Cancer Development: a pooled case-control study.
medRxiv
Lin N, Balasubramanian R, Menichetti G, Eliassen AH, Trabert B, Avila-Pacheco J, Townsend MK, Terry KL, Clish CB, Tworoger SS, Zeleznik OA.
PMID: 42922603 [PubMed]


The molecular pathological basis and potential clinical applications of 'zero-budding' status in stage II colorectal cancer.
J Pathol Clin Res
Liu YN, Wang B, Xu Q.
PMID: 42922155 [PubMed - indexed for MEDLINE]


COMP and CXCL10: a novel immunogenic cell death-derived gene signature for prognostic prediction in colorectal cancer.
PeerJ
Tang R, Li Y, Liu M, Tao X, Shen T, Wu T.
PMID: 42921266 [PubMed - indexed for MEDLINE]


Context dependent interactions between protozoan infections and cancer biology-a retrospective review.
Front Immunol
Yu F, Wu Z, Huang Y, Qi X, Wu J, Qin Y.
PMID: 42920976 [PubMed - indexed for MEDLINE]


A randomized Phase 1 study of telisotuzumab adizutecan (ABBV-400, Temab-A) in combination with bevacizumab versus trifluridine-tipiracil with bevacizumab in patients with metastatic colorectal cancer.
Ann Oncol
Cecchini M, Cruz-Correa M, Han SW, Raghav K, Landa-Magdalena A, Strickler JH, Calvo A, Hollebecque A, Nakajima TE, Perl G, Jain V, Hunter Z, Chan EM, Blaney M, Li R, Vasilopoulos A, Parikh A, Sharma MR.
PMID: 42926107 [PubMed - as supplied by publisher]


Final results of nivolumab plus ipilimumab versus nivolumab or chemotherapy in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW.
Ann Oncol
Lonardi S, Lenz HJ, Elez E, Jensen LH, Van Cutsem E, Touchefeu Y, García-Carbonero R, Tougeron D, Mendez GA, Schenker M, Fouchardière C, Mirón MLL, Yoshino T, Li J, Mozo JLM, Dahan L, Tortora G, Chalabi M, Goekkurt E, Braghiroli MI, Joshi R, Cil T, Aubin F, Raparthi V, Wang A, Rodriguez S, Cela E, Li L, Tam R, Jin L, André T.
PMID: 42926106 [PubMed - as supplied by publisher]


14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.
Lancet
Sakakida T, Taniguchi H, Asayama M, Suwa Y, Shimura T, Mitani S, Makiyama A, Arai H, Matsuoka H, Yokota M, Takano Y, Kato K, Oda H, Kajiwara T, Ogawa K, Shibata N, Sawada K, Yomoda T, Kudo T, Okuda H, Okumura Y, Tanaka C, Nakamura M, Tsuda T, Kitajima T, Tsukuda H, Shinozaki E, Furuta M, Kashiwada T, Okuya K, Mushiake H, Hasegawa J, Nihei K, Mizushima T, Mine T, Mizukami T, Kudo C, Mishima A, Murotani K, Masuishi T, PRABITAS investigators.
PMID: 42925880 [PubMed - as supplied by publisher]


Descriptive survival outcomes of fruquintinib-based PD-1 inhibitor strategies in advanced colorectal cancer reported as pMMR/MSS: a reconstructed-data analysis of prospective studies.
Cancer Treat Res Commun
Ge Y, Xia Y, Lin GH, Fu C, Kuang BH, Wang BC.
PMID: 42925845 [PubMed - as supplied by publisher]


Incorporating visceral adipose tissue into dual-region deep learning radiomics on CT improves preoperative lymph node metastasis prediction in gastric cancer: A multicenter study.
Eur J Radiol
Miao S, Xiong Z, Yang H, Zhang L, Qi H, Liu Z, Wang Q, Ding X, Wang R, Lu P.
PMID: 42925841 [PubMed - as supplied by publisher]


Japanese Society for Hereditary Tumors Guidance: Hereditary Cancer Syndromes With Multigene Panel Testing, 2025 Edition.
Cancer Sci
Yoshida R, Hirasawa A, Imoto I, Yamaguchi T, Kumamoto K, Momoko A, Ueki A, Masuda K, Urakawa Y, Tanabe N, Watanabe A, Hirata M, Aruga T, Kuwata T, Okugawa Y, Kaneko K, Terui-Kohbata H, Matsumoto M, Ueno S, Oda K, Ono H, Sakurai A, Matsui H, Yamamoto G, Yamamoto H, Yamamoto Y, Ikegami M, Ohkuma Y, Shien K, Suzuki S, Takayanagi S, Tanabe M, Hasumi H, Hatta N, Hattori H, Matsubayashi H, Yamagami W, Yamada M, Oishi K, Oka T, Oda S, Kobayashi Y, Takekoshi K, Nakajima T, Nakano Y, Nakayama Y, Miura F, Miyakura Y, Mori Y, Yoshimura A, Yonamine M, Shigeyasu K, Fujita H, Futagawa M, Ohta K, Kawano J, Tokutomi T, Sato A, Makabe T, Yoshihama T, Aitani M, Kimura K, Takaiso N, Tomozawa C, Hiraoka Y, Matsukawa M, Ishida H.
PMID: 42925246 [PubMed - as supplied by publisher]


Multimodal prehabilitation in colorectal cancer surgery: randomized clinical trial.
BJS Open
Bjerregaard F, Pekkari K, Asklid D, Anderin C, Westberg K, Marsk R, Gustafsson UO.
PMID: 42925093 [PubMed - indexed for MEDLINE]


Measures of physical fitness and postoperative mortality in patients with colorectal cancer: national cohort study.
BJS Open
Rashid A, Blake HA, Watton L, Fearnhead NS, Han L, van der Meulen J, Walker K.
PMID: 42925090 [PubMed - indexed for MEDLINE]


Immune remodeling in inflammatory bowel disease-associated colorectal cancer: Mechanisms and immunotherapeutic implications (Review).
Int J Mol Med
Zhang T, Ren Z, Wang L, Man R, Wang L, Wang J, Cheng X, Peng J, Yu Y.
PMID: 42924590 [PubMed - indexed for MEDLINE]


The Economic Value of Hereditary Cancer Testing: A Systematic Review.
Genet Med
Kirshner C, Carter GC, Heald B, Hartzfeld D, Johnson H, Xiao J, Kong J, Thompson G, Sancar F, Peters ML.
PMID: 42924496 [PubMed - as supplied by publisher]


Integrative Untargeted Metabolomics, Network Pharmacology, and Molecular Docking Identify Candidate Anti-Gastric Cancer Mechanisms of Zhishi Dahuang Decoction.
Biomed Chromatogr
Zhang L, Zhao X, Shi B, Zhou N, Xiong D, Chen X, Ji L, Shen Q, Lv Y.
PMID: 42924494 [PubMed - indexed for MEDLINE]


Metaplasia and the Origins of Gastric Cancer-Implications for Screening and Surveillance.
J Gastroenterol Hepatol
Yeoh KG.
PMID: 42922352 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 246457    Seite 1 von 12323  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1